DNA-Based Biomarkers as Predictors of Carboplatin Response in Neoadjuvant Treatment for Hormone Receptor Positive and Triple-Negative Breast Cancer
Year: 2026
Type: article
Study design: Clinical Trial
Source: Clinical Cancer Research
Authors: Arne V. Pladsen, Marianne L. Smebye, Øystein Garred, Elin Borgen, Eivind V. Egeland, Mads H. Haugen, Maria A. Dahle, Lina Prasmickaite, Gunhild M. Mælandsmo, Eivind Hovig, Sigve Nakken, Alexandra Østgaard, Inger R. Bergheim, Kristin Reinertsen, Hege Oma Ohnstad, Ellen Schlichting, Helle K. Skjerven, Anne-Lise B. Dale, Erik Wist, Bjørn Naume, Hege G. Russnes, Ole Christian Lingjærde, Olav Engebraaten
Institutions: Oslo University Hospital, University of Oslo
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7221812841
FWCI:
Cites:
Cited by:
Related to: